Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This binding reduces calcium influx into neurons, which in turn lowers the release of excitatory neurotransmitters such as glutamate and substance P. The result is decreased neuronal excitability and reduced transmission of pain signals.

The appropriate dose of Neurontin is individualized and set by a qualified prescriber based on the specific indication, patient age, renal function, and response to therapy. Dosage adjustments may be needed for patients with impaired kidney function or when used in combination with other central nervous system depressants.

Gabapentin is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus and there are no well‑controlled studies in pregnant women. It may be used during pregnancy only if the potential benefit justifies any potential risk. Gabapentin is excreted in breast milk, so breastfeeding decisions should be made in consultation with a healthcare professional.

To request Neurontin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. After the enquiry, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any required temperature control), and assist with import documentation.

The primary alternative to gabapentin is pregabalin, another gabapentinoid with a similar mechanism of action. Pregabalin generally has higher bioavailability and may achieve therapeutic effects at lower doses, but both drugs share comparable efficacy for neuropathic pain and seizure control. Individual response, tolerability, and cost considerations often guide the choice between them.

Neurontin tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiration date printed on the packaging.

Neurontin is supplied as oral tablets that are swallowed whole with a glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal upset in some patients. The exact timing and frequency are determined by the prescribing clinician.

Serious risks include the development of suicidal thoughts or behavior, severe allergic reactions such as Stevens‑Johnson syndrome, and respiratory depression, especially when combined with other central nervous system depressants. Patients should seek immediate medical attention if they notice rash, mood changes, or difficulty breathing.

Neurontin should not be used by individuals with a known hypersensitivity to gabapentin or any of the tablet excipients. Caution is advised in patients with severe renal impairment who have not had dose adjustments, and in those taking multiple CNS depressants without close monitoring. Pregnant or breastfeeding women should only use it when clearly indicated by a healthcare professional.